Site‐specific anti‐tumor immunity: Differences in DC function, TGF‐β production and numbers of intratumoral Foxp3+ Treg
Open Access
- 29 April 2009
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 39 (5), 1323-1333
- https://doi.org/10.1002/eji.200838921
Abstract
Gliomas localized within the CNS are generally not rejected by the immune system despite being immunogenic. This failure of the immune system has been associated both with glioma‐derived immunosuppressive molecules and the immune‐privileged state of the CNS. However, the relative contribution of tumor location to the glioma‐mediated immunosuppression, as well as the immune mechanisms involved in the failure of glioma rejection are not fully defined. We report here that syngeneic GL261 gliomas growing either intracranially or subcutaneously in mice are infiltrated by DC and T cells. However, only subcutaneous gliomas elicit an effective anti‐tumor immune response. In contrast to DC infiltrating subcutaneously grown GL261 gliomas, tumor‐infiltrating DC from intracranial gliomas do not activate antigen‐dependent T‐cell proliferation in vitro. In addition, brain‐localized GL261 gliomas are characterized by significantly higher numbers of Foxp3+ Treg and higher levels of TGF‐β1 mRNA and protein expression when compared with GL261 gliomas in the skin. Our data show that gliomas in the CNS, but not in the skin, give rise to TGF‐β production and accumulation of both Treg and functionally impaired DC. Thus, not the tumor itself, but its location dictates the efficiency of the anti‐tumor immune response.Keywords
This publication has 51 references indexed in Scilit:
- In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumorThe Journal of Experimental Medicine, 2007
- Defective Receptor Expression and Dendritic Cell Differentiation of Monocytes in GlioblastomasNeurosurgery, 2006
- An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme1Neuro-Oncology, 2006
- Regulatory T cells, tumour immunity and immunotherapyNature Reviews Immunology, 2006
- Microglial cell activation and proliferation precedes the onset of CNS autoimmunityJournal of Neuroscience Research, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 The Journal of Experimental Medicine, 2003
- Prostaglandin E2 levels in human brain tumor tissues and arachidonic acid levels in the plasma membrane of human brain tumorsCancer Letters, 1998
- Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsNature Medicine, 1996
- Bronchiolo-alveolar carcinoma: An analysis of survival predictorsEuropean Journal Of Cancer, 1992